Viewing Study NCT02814968


Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2026-01-24 @ 7:09 AM
Study NCT ID: NCT02814968
Status: COMPLETED
Last Update Posted: 2022-04-14
First Post: 2016-06-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide
Sponsor: The European Uro-Oncology Group
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: EudraCT Number 2014-001161-27
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View